These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23434829)

  • 1. Upregulation of drug transporter expression by osteopontin in prostate cancer cells.
    Hsieh IS; Huang WH; Liou HC; Chuang WJ; Yang RS; Fu WM
    Mol Pharmacol; 2013 May; 83(5):968-77. PubMed ID: 23434829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
    Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
    Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
    Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin-integrin α(v)β(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma.
    Nakamura T; Shinriki S; Jono H; Ueda M; Nagata M; Guo J; Hayashi M; Yoshida R; Ota T; Ota K; Kawahara K; Nakagawa Y; Yamashita S; Nakayama H; Hiraki A; Shinohara M; Ando Y
    FEBS Lett; 2015 Jan; 589(2):231-9. PubMed ID: 25497015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression.
    Zhang Y; Forootan SS; Kamalian L; Bao ZZ; Malki MI; Foster CS; Ke Y
    Int J Oncol; 2011 Apr; 38(4):1083-91. PubMed ID: 21290088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of osteopontin downregulation on the growth of prostate cancer PC-3 cells.
    Zheng J; Hou ZB; Jiao NL
    Mol Med Rep; 2011; 4(6):1225-31. PubMed ID: 21842122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
    Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
    Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma.
    Weismann D; Briese J; Niemann J; Grüneberger M; Adam P; Hahner S; Johanssen S; Liu W; Ezzat S; Saeger W; Bamberger AM; Fassnacht M; Schulte HM; Asa SL; Allolio B; Bamberger CM
    J Pathol; 2009 Jun; 218(2):232-40. PubMed ID: 19326399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin.
    Liu J; Ren Y; Kang L; Zhang L
    Int J Mol Med; 2014 May; 33(5):1341-7. PubMed ID: 24590381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.
    Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
    Am J Pathol; 2014 Mar; 184(3):842-58. PubMed ID: 24412090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
    Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
    Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteopontin, inhibiting apoptosis downstream of caspase-3.
    Graessmann M; Berg B; Fuchs B; Klein A; Graessmann A
    Oncogene; 2007 May; 26(20):2840-50. PubMed ID: 17160024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
    Tilli TM; Mello KD; Ferreira LB; Matos AR; Accioly MT; Faria PA; Bellahcène A; Castronovo V; Gimba ER
    Prostate; 2012 Nov; 72(15):1688-99. PubMed ID: 22495819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin O-glycosylation contributes to its phosphorylation and cell-adhesion properties.
    Kariya Y; Kanno M; Matsumoto-Morita K; Konno M; Yamaguchi Y; Hashimoto Y
    Biochem J; 2014 Oct; 463(1):93-102. PubMed ID: 25000122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.
    Tajima K; Ohashi R; Sekido Y; Hida T; Nara T; Hashimoto M; Iwakami S; Minakata K; Yae T; Takahashi F; Saya H; Takahashi K
    Oncogene; 2010 Apr; 29(13):1941-51. PubMed ID: 20101228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin modulates malignant pleural mesothelioma cell functions in vitro.
    Ohashi R; Tajima K; Takahashi F; Cui R; Gu T; Shimizu K; Nishio K; Fukuoka K; Nakano T; Takahashi K
    Anticancer Res; 2009 Jun; 29(6):2205-14. PubMed ID: 19528482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.